SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is attracting significant community attention and discussion, particularly as its proponents rally around the upcoming 4/20 event, promoting its mission to advance global cannabis culture and legalization on the Solana blockchain as a crypto 'like Bitcoin but way higher'.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending due to its highly active community's relentless focus on building a "permissionless brand," highlighted by the continuous launch of real-world products like "Kendu Spice" and "Kendu Unleashed" skateboards. The community remains overwhelmingly bullish, emphasizing the project's strong fundamentals and long-term vision amidst prevailing market conditions.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares (LABU) is experiencing a strong rally, propelled by increasing market conviction in AI's transformative role in drug discovery, significant M&A activity, and growing expectations for rate cuts that are driving a sector-wide breakout.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending amidst community frustration and significant losses as the biotech sector (XBI) maintains an unexpected bull run, driven by ongoing M&A and perceived market manipulation, defying numerous bearish technical indicators.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

GHOST Crypto is gaining attention as the "Full Stack Privacy Layer of Solana," with its low market cap and utility-focused partnerships driving community excitement for substantial growth and anticipated "rev share" in a market embracing privacy solutions.

WorldFinancial

WLFI is trending as it faces a U.S. House investigation into a significant $500 million investment deal, sparking a polarized community debate. While many critics denounce it as a politically-linked "scam," proponents are aggressively buying dips, anticipating future growth from its planned app and real-world asset tokenization initiatives.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Amidst broader market volatility and a rotation out of tech, the Schwab US Dividend Equity ETF (SCHD) is trending as a defensive safe haven, with investors celebrating its recent price appreciation and consistent dividend growth, though some debate if it's becoming overbought.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

A recent analyst upgrade to Buy, citing Core Scientific's AI infrastructure pivot and strong demand for high-performance computing, is currently battling significant selling pressure. The community is actively discussing perceived delays in its data center capacity delivery, particularly impacting a major client, which has reignited debates over past strategic decisions and the stock's future trajectory.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is trending as its collaboration with OpenAI on an AI-driven autonomous lab, achieving significant cost reductions in protein synthesis, sparks community debate on its potential as critical national biotechnology infrastructure amid broader sector tailwinds for AI and biodefense.

Realty Income Corp. is a real estate company, which engages in generating dependable monthly cash dividends from a consistent and predictable level of cash flow from operations. The company was founded by William E. Clark, Jr. and Evelyn Joan Clark in 1969 and is headquartered in San Diego, CA.

Realty Income Corp.

Realty Income is trending due to recent analyst upgrades, strategic partnerships expanding its footprint into logistics and gaming, and its consistent monthly dividend increases, fueling community discussion around its role as a stable income play. Many anticipate that potential interest rate cuts will further boost this prominent REIT, making its attractive yield even more compelling, though some debate its growth prospects.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Christine Berni Silverstein Sells 20,070 Shares of Abeona Therapeutics (NASDAQ:ABEO) Stock

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) Director Christine Berni Silverstein sold 20,070 shares of the firm's stock in a transaction dated Monday, February 2nd. The shares were sold...

Eric Crombez Sells 16,284 Shares of Abeona Therapeutics (NASDAQ:ABEO) Stock

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) Director Eric Crombez sold 16,284 shares of the business's stock in a transaction on Monday, February 2nd. The shares were sold at an average...

Abeona Therapeutics (NASDAQ:ABEO) Insider Madhav Vasanthavada Sells 12,610 Shares of Stock

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) insider Madhav Vasanthavada sold 12,610 shares of the company's stock in a transaction that occurred on Thursday, January 22nd. The stock was...

Insider Selling: Abeona Therapeutics (NASDAQ:ABEO) CEO Sells 69,832 Shares of Stock

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) CEO Vishwas Seshadri sold 69,832 shares of the business's stock in a transaction on Thursday, January 22nd. The shares were sold at an average...

Abeona Therapeutics (NASDAQ:ABEO) SVP Sells $72,370.74 in Stock

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) SVP Brendan O'malley sold 13,578 shares of the company's stock in a transaction on Thursday, January 22nd. The shares were sold at an average...

Joseph Walter Vazzano Sells 18,666 Shares of Abeona Therapeutics (NASDAQ:ABEO) Stock

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) CFO Joseph Walter Vazzano sold 18,666 shares of the company's stock in a transaction that occurred on Thursday, January 22nd. The shares were...

Abeona Therapeutics (NASDAQ:ABEO) CEO Sells $372,204.56 in Stock

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) CEO Vishwas Seshadri sold 69,832 shares of the business's stock in a transaction that occurred on Thursday, January 22nd. The shares were sold...

Abeona Therapeutics (NASDAQ:ABEO) Director Mark Alvino Sells 13,500 Shares of Stock

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) Director Mark Alvino sold 13,500 shares of the firm's stock in a transaction dated Wednesday, January 21st. The stock was sold at an average...

Abeona Therapeutics (NASDAQ:ABEO) Director Mark Alvino Sells 13,500 Shares

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) Director Mark Alvino sold 13,500 shares of the business's stock in a transaction on Wednesday, January 21st. The stock was sold at an average...

Abeona Therapeutics (NASDAQ:ABEO) Share Price Passes Above 50-Day Moving Average - Here's What Happened

Abeona Therapeutics (NASDAQ:ABEO) Stock Price Passes Above 50 Day Moving Average - Should You Sell...

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.35	--	--	N/A
Q3 '25	-$0.28	-$0.10	64.54%	BEAT
Q2 '25	-$0.39	$1.71	538.46%	BEAT
Q1 '25	-$0.36	-$0.24	32.96%	BEAT
Q4 '24	-$0.35	$0.50	243.68%	BEAT

ABEO
Abeona Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest ABEO News

ABEOAbeona Therapeutics Inc